Adrienne W. Scott, MD1; Angela R. Elam, MD2; Kristen Nwanyanwu, MD, MBA, MHS3
doi : 10.1001/jamaophthalmol.2021.2053
JAMA Ophthalmol. 2021;139(9):935-936
Wajiha Jurdi Kheir, MD1; Shady T. Awwad, MD1; Alaa Bou Ghannam, MD1; Ali A. Khalil, MD1; Perla Ibrahim, MD1; Elza Rachid, MD1; Nasrine Anais El Salloukh, MD1; Madeleine Yehia, MD1; Julien Torbey, MD1; Lulwa El Zein, MD1; Nada S. Jabbur, MD1,2,3; Baha Noureddin, MD1; Ramzi M. Alameddine, MD1
doi : 10.1001/jamaophthalmol.2021.2742
JAMA Ophthalmol. 2021;139(9):937-943
A review of the injury patterns, treatment strategies, and responding physicians’ experience during the Port of Beirut blast may help guide future ophthalmic disaster response plans.
David M. Brown, MD1; Charles C. Wykoff, MD, PhD1,2; David Boyer, MD3; Jeffrey S. Heier, MD4; W. Lloyd Clark, MD5; Andres Emanuelli, MD6,7; Patrick M. Higgins, MD8; Michael Singer, MD9; David M. Weinreich, MD10; George D. Yancopoulos, MD, PhD10; Alyson J. Berliner, MD, PhD10; Karen Chu, MS10; Kimberly Reed, OD10; Yenchieh Cheng, PhD10; Robert Vitti, MD10
doi : 10.1001/jamaophthalmol.2021.2809
JAMA Ophthalmol. 2021;139(9):946-955
Proactive treatment of nonproliferative diabetic retinopathy (NPDR) reduces the risk of progression to vision-threatening complications.
Claudio Azzolini, MD1; Simone Donati, MD1; Elias Premi, MD1; Andreina Baj, MD2; Claudia Siracusa, BMedBiol3; Angelo Genoni, BMedSci4; Paolo A. Grossi, MD5; Lorenzo Azzi, MD6; Fausto Sessa, MD7; Francesco Dentali, MD8; Paolo Severgnini, MD9; Giulio Minoja, MD10; Luca Cabrini, MD11; Maurizio Chiaravalli, MD12; Giovanni Veronesi, MD13; Giulio Carcano, MD14; Lorenzo S. Maffioli, MD15; Angelo Tagliabue, MD6,16
doi : 10.1001/jamaophthalmol.2020.5464
JAMA Ophthalmol. 2021;139(9):956-963
Since February 2020, coronavirus disease 2019 (COVID-19) has spread rapidly all over the world, with an epidemiological cluster in Lombardy, Italy. The viral communicability may be mediated by various body fluids, but insufficient information is available on the presence of the virus in human tears.
Marc Wilson, BCom, BIT1; Reena Chopra, BSc1,2,3; Megan Z. Wilson, MSci1; Charlotte Cooper, DPhil1; Patricia MacWilliams, MSc1; Yun Liu, PhD4; Ellery Wulczyn, MS4; Daniela Florea, PhD2,3; C?an O. Hughes, MBChB, MSc1; Alan Karthikesalingam, MSc, MA, PhD1; Hagar Khalid, MD2,3; Sandra Vermeirsch, MD2,3; Luke Nicholson, MD2,3; Pearse A. Keane, MD2,3; Konstantinos Balaskas, MD2,3; Christopher J. Kelly, MB BChir, PhD1
doi : 10.1001/jamaophthalmol.2021.2273
JAMA Ophthalmol. 2021;139(9):964-973
Quantitative volumetric measures of retinal disease in optical coherence tomography (OCT) scans are infeasible to perform owing to the time required for manual grading. Expert-level deep learning systems for automatic OCT segmentation have recently been developed. However, the potential clinical applicability of these systems is largely unknown.
Huan Chen, MD1; Xuefeng Pan, MD2; Jingyuan Yang, MD1; Jing Fan, MD3; Mingwei Qin, MD3; Hu Sun, BSc4; Jinxin Liu, PhD5; Na Li, PhD5; Daniel Shu Wei Ting, MD, PhD6; Youxin Chen, MD, PhD1
doi : 10.1001/jamaophthalmol.2021.2312
JAMA Ophthalmol. 2021;139(9):975-982
Interest in teleophthalmology has been growing, especially during the COVID-19 pandemic. The advent of fifth-generation (5G) wireless systems has the potential to revolutionize teleophthalmology, but these systems have not previously been leveraged to conduct therapeutic telemedicine in the ophthalmology field.
Amanda K. Bicket, MD, MSE1; Jimmy T. Le, MA, ScD2; Augusto Azuara-Blanco, PhD, FRCSEd, FRCOphth3; Gus Gazzard, MA, MB BChir, MD, FRCOphth4,5; Richard Wormald, MSc, FRCS, FRCOphth6,7; Catey Bunce, DSc8; Kuang Hu, MA, MBBChir, PhD, FRCOphth4; Hari Jayaram, MBBS, PhD, FRCSEd4,5; Anthony King, MD, FRCOphth9; Francisco Ot?rola, MD4,10; Eleni Nikita, FRCOphth4; Anupa Shah, BA6; Richard Stead, FCOphth9; M?rta T?th, MD, PhD4; Tianjing Li, MD, MHS, PhD11
doi : 10.1001/jamaophthalmol.2021.2351
JAMA Ophthalmol. 2021;139(9):983-989
Glaucoma affects more than 75 million people worldwide. Intraocular pressure (IOP)–lowering surgery is an important treatment for this disease. Interest in reducing surgical morbidity has led to the introduction of minimally invasive glaucoma surgeries (MIGS). Understanding the comparative effectiveness and safety of MIGS is necessary for clinicians and patients.
Shu Wang, MD1,2,3; Wen Wen, MD, PhD1,2,3; Wenqing Zhu, MD, PhD1,2,3; Yan Liu, MD, PhD1,2,3; Leilei Zou, MD, PhD1,2,3; Tian Tian, MD, PhD1,2,3; Jing Lin, Jnr Tech1,2,3; Rui Liu, MD, PhD1,2,3; Hong Liu, MD, PhD1,4
doi : 10.1001/jamaophthalmol.2021.2413
JAMA Ophthalmol. 2021;139(9):990-996
Patching is often less effective for severe amblyopia because of poor adherence. For the treatment of severe amblyopia, although combined atropine and patching therapy (CAPT) has been found to be efficacious, it is currently unknown whether CAPT is more efficacious than patching alone.
Shrinivas Pundlik, PhD1,2; Vilte Baliutaviciute, BS1,3; Mojtaba Moharrer, PhD1,2; Alex R. Bowers, PhD1,2; Gang Luo, PhD1,2
doi : 10.1001/jamaophthalmol.2021.2624
JAMA Ophthalmol. 2021;139(9):998-1005
There is scant rigorous evidence about the real-world mobility benefit of electronic mobility aids.
Gilles Guerrier, MD, PhD1,2; Hendy Abdoul, MD, PhD3; Lea Jilet, MsC3; Pierre-Raphaël Rothschild, MD, PhD2,4; Christophe Baillard, MD, PhD1
doi : 10.1001/jamaophthalmol.2021.2767
JAMA Ophthalmol. 2021;139(9):1007-1013
Hypertensive events during cataract surgery may induce complications. Information and communication technologies applied to health are popular, but clinical evidence of its usefulness is rare and limited to treating anxiety without specific analysis. Recent publications have described the potential effects of personalized music choices as mobile-based intervention on pain but not on anxiety.
Carlla A. Araujo-Silva, MSc1,2,3; Alléxya A. A. Marcos, MD4,5; Paula M. Marinho, MD4,5,6; Ana M. C. Branco, MD4; Alexandre Roque, MD6; André C. Romano, MD4,5; Mateus L. Matuoka, MD6; Michel Farah, MD, PhD4,5; Miguel Burnier, MD, PhD7; Nara F. Moraes, MD6; Paulo F. G. M. M. Tierno, MD6; Paulo Schor, MD, PhD4,5; Victoria Sakamoto, MD4; Heloisa Nascimento, MD, PhD4,5,6; Wanderley de Sousa, MD, PhD1,2,3; Rubens Belfort Jr, MD, PhD4,5
doi : 10.1001/jamaophthalmol.2021.2795
JAMA Ophthalmol. 2021;139(9):1015-1021
The presence of the SARS-CoV-2 virus in the retina of deceased patients with COVID-19 has been suggested through real-time reverse polymerase chain reaction and immunological methods to detect its main proteins. The eye has shown abnormalities associated with COVID-19 infection, and retinal changes were presumed to be associated with secondary microvascular and immunological changes.
Owen M. Siggs, MD, DPhil1,2; Xikun Han, MSc3; Ayub Qassim, MBBS, PhD1; Emmanuelle Souzeau, PhD1; Shilpa Kuruvilla, MBBS1; Henry N. Marshall1; Sean Mullany, MD1; David A. Mackey, MD4,5; Alex W. Hewitt, MBBS, PhD4,6; Puya Gharahkhani, PhD3; Stuart MacGregor, PhD3; Jamie E. Craig, MBBS, DPhil1
doi : 10.1001/jamaophthalmol.2021.2440
JAMA Ophthalmol. 2021;139(9):1023-1028
Early diagnosis of open-angle glaucoma can lead to vision-saving treatment, and genetic variation is an increasingly powerful indicator in disease risk stratification.
Trisha Lal, BS1; Zu-Xi Yu, MD, PhD2; Bin Guan, PhD1; Chelsea Bender, BS3; Chi-Chao Chan, MD4; Catherine A. Cukras, MD, PhD5; Robert B. Hufnagel, MD, PhD1
doi : 10.1001/jamaophthalmol.2021.2688
JAMA Ophthalmol. 2021;139(9):1029-1032
Asymmetric retinitis pigmentosa (RP) is a rare presentation of a normally symmetric condition. Histopathologic evidence should be examined to see if this asymmetry extends to the tissue and cellular levels.
Richard J. Blanch, MBChB(Hons), PhD1,2,3; Robert A. Mazzoli, MD4; Keith Porter, MBBS5
doi : 10.1001/jamaophthalmol.2021.2707
JAMA Ophthalmol. 2021;139(9):943-945
Bianca S. Gerendas, MD, PhD1,2; Hrvoje Bogunovi?, PhD1,2; Ursula Schmidt-Erfurth, MD1,2
doi : 10.1001/jamaophthalmol.2021.2309
JAMA Ophthalmol. 2021;139(9):973-974
David C. Musch, PhD, MPH1,2; John D. Baker, MD3,4
doi : 10.1001/jamaophthalmol.2021.2425
JAMA Ophthalmol. 2021;139(9):996-997
Gerald McGwin Jr, MS, PhD1,2; Cynthia Owsley, PhD, MSPH1
doi : 10.1001/jamaophthalmol.2021.2633
JAMA Ophthalmol. 2021;139(9):1005-1006
Julie M. Schallhorn, MD1; Jennifer Rose-Nussbaumer, MD1,2
doi : 10.1001/jamaophthalmol.2021.2706
JAMA Ophthalmol. 2021;139(9):1013-1014
Nasreen A. Syed, MD1,2; Charles Grose, MD3
doi : 10.1001/jamaophthalmol.2021.2806
JAMA Ophthalmol. 2021;139(9):1021-1022
Andrew T. Melson, MD1; Anil D. Patel, MD1
doi : 10.1001/jamaophthalmol.2020.6586
JAMA Ophthalmol. 2021;139(9):1033-1034
Mateusz Kecik, MD1; Alexandros Stangos, MD1; Ariane Malclès, MD1
doi : 10.1001/jamaophthalmol.2020.6852
JAMA Ophthalmol. 2021;139(9):1035-1036
Mark P. Breazzano, MD1,2; Stanley Chang, MD1
doi : 10.1001/jamaophthalmol.2020.6869
JAMA Ophthalmol. 2021;139(9):1037-1038
Benjamin J. Fowler, MD, PhD1; Jimmy L. Nguyen, OD1; Jayanth Sridhar, MD1
doi : 10.1001/jamaophthalmol.2020.7095
JAMA Ophthalmol. 2021;139(9):1039-1040
Miguel Ortiz-Salvador, MD1; Javier Montero-Hern?ndez, MD1; Rafael Freir?a-Barreiro, MD1
doi : 10.1001/jamaophthalmol.2021.3312
JAMA Ophthalmol. 2021;139(9):e213312
Sashwanthi Mohan, MBBS, DNB, FICO1; Sujatha Mohan, DO, FRCS1
doi : 10.1001/jamaophthalmol.2021.3320
JAMA Ophthalmol. 2021;139(9):e213320
Francesca Colavita, PhD1; Salvatore Curiale, Dr1; Daniele Lapa, PhD1; Concetta Castilletti, PhD1
doi : 10.1001/jamaophthalmol.2021.2681
JAMA Ophthalmol. 2021;139(9):1041
Claudio Azzolini, MD1; Simone Donati, MD1; Elias Premi, MD1
doi : 10.1001/jamaophthalmol.2021.2751
JAMA Ophthalmol. 2021;139(9):1041-1042
Do you want to add Medilib to your home screen?